Strong Association of Metabolic Parameters with ADMA and VCAM-1 in Normo-Weight Subjects with Metabolic Syndrome
Iis Rakhmat,Gaga Nugraha,Eko Ariyanto,Yuni Pratiwi,Desy Linasari,Siti Fatimah,Mohammad Ghozali,Mas Syamsunarno,Mohammad Akbar,Tri Achmad
DOI: https://doi.org/10.2147/dmso.s448650
2024-02-19
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Iis Inayati Rakhmat, 1– 3 Gaga Irawan Nugraha, 3, 4 Eko Fuji Ariyanto, 3, 4 Yuni Susanti Pratiwi, 3, 4 Desy Linasari, 5 Siti Nur Fatimah, 3, 6 Mohammad Ghozali, 3, 4 Mas Rizky AA Syamsunarno, 3, 4 Mohammad Rizki Akbar, 3, 7 Tri Hanggono Achmad 3, 4 1 Doctoral Study Program Faculty of Medicine, Universitas Padjadjaran, Bandung, West Java, Indonesia; 2 Department of Biochemistry, Faculty of Medicine, Universitas Jenderal Achmad Yani, Cimahi, West Java, Indonesia; 3 Cardiometabolic Working Group Study, Faculty of Medicine, Universitas Padjadjaran, Bandung, West Java, Indonesia; 4 Department of Biomedical Sciences, Faculty of Medicine, Universitas Padjadjaran, Bandung, West Java, Indonesia; 5 Department of Community Medicine, Faculty of Medicine, Universitas Jenderal Achmad Yani, Cimahi, West Java, Indonesia; 6 Department of Public Health, Faculty of Medicine, Universitas Padjadjaran, Bandung, West Java, Indonesia; 7 Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Padjadjaran-Hasan Sadikin General Hospital, Bandung, West Java, Indonesia Correspondence: Gaga Irawan Nugraha, Department of Biomedical Sciences, Faculty of Medicine, Universitas Padjadjaran, Eycmann 38, Bandung, West Java, 40161, Indonesia, Tel/Fax +6222 2032170, Email Background: Metabolic syndrome (MetS) is a risk factor for cardiovascular disease and is linked to obesity. Subjects with MetS who have normo-weight potentially show higher mortality and morbidity. Purpose: This study aims to reveal the critical essential metabolic parameters associated with endothelial dysfunction in MetS subjects with normo-weight compared to obese. Patients and Methods: The study was designed using a case–control approach. Ninety-nine MetS subjects (34 Normo-weight and 65 obese) from the urban population were enrolled in this study. The components of MetS are based on NCEP/ATP III criteria. Asymmetric dimethylarginine (ADMA) and vascular cell adhesion molecule 1 (VCAM-1) as markers for endothelial dysfunction were measured in both groups. Results: Fasting blood glucose (FBG) levels were higher in the normo-weight group (143.38 ± 79.8 mg/dL) compared to the obese group (120.89 ± 46.5 mg/dL). High-density lipoprotein cholesterol (HDL-c) levels in the normo-weight group were lower (42.82 ± 10.1 mg/dL) compared to obesity (45.74 ± 9.3 mg/dL), while triacylglycerol (TAG) levels were higher in the obese (197.25 ± 110.5 mg/dL) compared to the normo-weight group (167.03 ± 98.4 mg/dL), although the differences were statistically not significant (all p > 0.05). The difference between ADMA and VCAM-1 levels was statistically not significant in both groups. Correlation between MetS components with endothelial dysfunction parameters shows that metabolic parameters correlate strongly. Interestingly, a stronger correlation between FBG and ADMA was observed in normo-weight (r = 0.519) compared to obese groups (r = 0.445). In addition, TAG consistently shows a significant correlation with ADMA and VCAM-1 in normo-weight groups. Conclusion: Metabolic parameters, especially FBG and TAG, correlate strongly with endothelial dysfunction parameters in normo-weight subjects with metabolic syndrome. Keywords: ADMA, normal-weight metabolically unhealthy, VCAM-1 Cardiovascular disease remains a significant global threat, with 17.9 million people dying from it in 2016, accounting for 31% of all global deaths. 1 Metabolic syndrome (MetS) is a common condition worldwide linked to an increased risk of cardiovascular events and diabetes mellitus. 2–4 Metabolic syndrome, initially linked to obesity, can also occur in normo-weight adults. 5 Interestingly, recent studies in the US revealed that the mortality rate in normal-weight MetS patients was even higher than in obese MetS patients. 6 These findings raise the issue of which MetS criteria influence more to cardiovascular events rather than obesity. 7–10 Several criteria have been developed to diagnose MetS, including central obesity, elevated TAG, low HDL-c, elevated fasting blood sugar, and hypertension. 2,3 These criteria can also be found in normo-weight subjects. 9,10 Several studies have reported metabolically unhealthy subjects with cardiovascular disease, 5,6,8,10,11 associated with endothelial dysfunction, and alteration in ADMA and VCAM-1 used as surrogate biomarkers. 12–15 This study aims to reveal the metabolic parameters primarily related to endothelial dysfu -Abstract Truncated-
endocrinology & metabolism